Joint Research Office
- What does the JRO do?
- Post Approval
- Academic Clinical Trials
- Commercial Research
- Training and Education
- Patient and Public Involvement
- Funding Opportunities
- JRO News
- Standard Operating Procedures
- Clinical Trials Units (CTUs)
Professor Rumana Omar
Rumana is a Professor of Medical Statistics at the Department of Statistical Science, UCL and head of
the Biostatistics Group at the Research Support Centre. Rumana has collaborated nationally and
internationally on large scale observational studies and trials. Her main
research interests are: case-mix/risk prediction models, both applied and
methodological aspects of cluster randomised trials, analysis of repeated
measurements data and meta-analysis.
Dr Gareth Ambler, Senior Lecturer
Gareth holds a joint post between the Biostatistics Group and the Department of Statistical Science at UCL. His main research interests are in the formulation and validation of diagnostic and prognostic models, clinical trials with multivariate outcomes, and clinical trial design. Gareth is co-investigator on numerous grants from funders such as NIHR, MRC, Wellcome Trust and EU FP7, and is the lead statistician on several clinical trials (both early phase and phase III).
Currently held grants include:
- RegenVOX: phase I/II clinical trial of stem cell based tissue engineered laryngeal implants (PI: Prof Martin Birchall), MRC (£2,772,000)
- Low-dose Intravenous Immunoglobulin Treatment for Complex Regional Pain Syndrome (‘LIPS’) randomised controlled trial (PI: Dr Andreas Goebel) NIHR EME (£647,645)
- Health-Related Quality of Life in two treatment pathways for primary open angle glaucoma and ocular hypertension: a randomised controlled trial of initial selective laser trabeculoplasty versus conventional medical therapy (PI: Dr Gus Gazzard) NIHR HTA (£1,692,821)
Dr Julie Barber, Lecturer
Julie holds a joint post between the Biostatistics Group and the Department of Statistical Science at UCL. She has more than 15 years experience of working on randomised trials and large epidemiological studies, taking a lead statistical role. She is a co-investigator on a number of collaborative projects supported by grants from NIHR, HTA and ESRC and covering research areas including mental health, cancer, heart disease, surgery and health services delivery. Julie has a particular interest in statistical issues in design and analysis of trials and in health economic evaluations.
Currently held grants include:
- The MARQUE project: Managing Agitation and Raising Quality of Life. A project to improve quality of life in people with dementia ESRC/NIHR programme grant (£3.2 million)
- The Essence of Specialist Teenage and Young Adult (TYA) Cancer Care NIHR programme grant (£1,995,994)
- SAFFRON: Developing a stepped approach to improving sexual function after treatment for gynaecological cancer HTA (£579,387)
Dr Zoe Fox, Lecturer
Zoe holds a joint post between the Biostatistics Group and the Institute of Neurology at UCL. She has successfully collaborated on major research projects run within the Prion unit, the Stroke unit and the Department of Neurosurgery in the Institute of Neurology. She continually collaborates with other members of staff in the Institute and advises PhD students on the best statistical approaches to use. Her main methodological areas of interest concern statistical issues in analysing observational studies in addition to novel methods used in clinical trials.
Fatima Jichi, Research Associate
Fatima's main research interests are in clinical trials, risk models and methodology for modelling longitudinal data. She has experience in clinical trials in Mental Health & Neuroscience.
Dr Matthew Burnell, Research Associate
Matthew provides statistical consultancy on a broad range of topics as well as teaching assistance. He also has a joint post in UCL’s Department of Women’s Cancer as the trial statistician in one of the world largest ever randomised controlled trials (over 200,000 women in an ovarian cancer screening trial) as well as multiple research collaborations with clinical and genetic experts both within and outside of UCL. His areas of interest naturally include cancer trials but also diverse subjects such as psychometric theory and pharmacokinetics.